/Companies

Applied Biological Laboratories

New York, US · Founded 2016 · Delaware corporation

Find your way into Applied Biological Laboratories

Sign up to see every warm intro you have to Applied Biological Laboratories

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Applied Biological Laboratories team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Applied Biological Laboratories develops antiviral biotechnology treatments targeting respiratory viruses using a patented biologic platform that combines host-directed immune modulation and microbe-directed mechanisms. The company conducts research using human respiratory organoids to identify and develop antiviral and anti-inflammatory therapeutic solutions.

Founders & leadership

PPPavel Pugach
Pavel PugachVice President of Research and DevelopmentHe has two decades of experience in virology and immunology, with expertise in antibody engineering, viral assays, cell biology, and gene editing technologies including CRISPR.
ML
Michael LatefiNamed on SEC filing
NL
Nazlie LatefiCo-Founder and Chief Executive Officer

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2016

▶$1MraisedMay 2016 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LatefiExecutive Officer, Director
  • Nazlie LatefiExecutive Officer, Director
Offering amount
$3M
Amount sold
$1M
First sale
May 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Applied Biological Laboratories.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
Centers for Disease Control and Prevention (CDC)Centers for Disease Control and PreventionPhase I2019$224.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Applied Biological Laboratories do?
Applied Biological Laboratories develops antiviral biotechnology treatments targeting respiratory viruses using a patented biologic platform that combines host-directed immune modulation and microbe-directed mechanisms. The company conducts research using human respiratory organoids to identify and develop antiviral and anti-inflammatory therapeutic solutions.
How much funding has Applied Biological Laboratories raised?
Applied Biological Laboratories has disclosed $1M raised across 1 round.
Where is Applied Biological Laboratories headquartered?
Applied Biological Laboratories is headquartered in New York, US.